褐煤超临界流体抽提产物中脂肪烃组成结构的特征

用硅胶-氧化铝柱色谱预分离和色谱-质谱分析研究了两种褐煤超临界流体抽提物中脂肪烃馏分组成结构特征。结果表明,除主要成份正构烷烃(C_(13)～C_(33))外,尚有少量的类异戊二烯烃(姥鲛烷、植烷等)和萜烷。其中萜烷以五环三萜为主(C_(27)、C_(29)～C_(32)藿烷类化合物),并有一定量的C_(27)、C_(29)和C_(30)藿烯,倍半萜和三环二萜烷含量很少。未检出甾烷。此外,还检出一完整系列的烯烃。试验结果表明,超临界流体抽提条件对褐煤抽出物各组分、含量及其分布有一定的影响。     

The Electrochemical Investigation of MEH-PPV in Ionic Liquid

Ionic liquids are a new kind of room-temperature molten organic salts. It can be used as solvents in the organic/polymeric syntheses, and some of them are called "green" solvents because of its recyclability1. Ionic liquids possess the superior properties, such as thermal stability up to 200(C, involatility and re-designability(for both cation and anion). The ionic liquid employed in this work is [bmim] [PF6]- ( butylmethylimidazolium hexafluorophosphate ) which is immiscible with water and h…     

富勒烯及其衍生物的质谱研究

本文制备了一系列富勒烯及其衍生物，并利用多种质谱技术进行了鉴定、表征、揭示了它们在离子源条件下的稳定性及解规律。这些富勒烯及其省生物在ＦＤＭＳ、ＩＳＭＳ中均得到了较强的准分子离子峰且碎片峰很少。结果表昨ＦＤＭＳ，ＬＳＩＭＳ技术均适于富勒烯及其衍生物的定性分析，是目前富勒烯分析鉴定中较好的方法。     

新显色剂1－（对－偶氮苯）－3－（2－噻唑）－三氮烯与锌显色反应的研究及应用

本文研究了新显色剂１－（对－偶氮苯）－３－（２－噻唑）－三氮烯在非离子表面活性剂ＴｒｉｔｏｎＸ－１００存在下，与锌（Ⅱ）显色反应的适宜条件。结果表明，在ｐＨ１３．０～１４．０范围内，锌（Ⅱ）与题示试剂形成１：３的稳定粉红色配合物，其最大吸收波长为５４５ｎｍ，试剂的最大吸收波长为４６３ｎｍ。配合物表现摩尔吸光系数在５４５ｎｍ处为９．６×１０￣４Ｌ·ｍｏｌ￣（－１）＊ｃｍ￣（－１）；０～２４μｇ／２５ｍＬＺｎ符合比耳定律。该试剂对锌的选择性良好。方法用于铝合金中锌的直接测定，结果令人满意。     

马来酸酐与乙酸乙烯酯交替共聚合反应的研究

本文研究了马来酸酐（MAn）在过氧化苯甲酰（BP）引发作用下与醋酸乙烯酯（VAc）的交替共聚反应。红外光谱证明了交替共聚物的结构，分析结果表明共聚物是由反应单体技1：1摩尔比例组成。当c（BPO）＝6．8×10~（－3）moi／L，c（VAc）＝3．4×10~（－3）mol／L，p（MAn）＝32．7g／L，63～65℃反应18小时，转化率可达92％以上。     

金属离子在煤界面吸附对煤成浆性的影响

本文研究了六种金属离子在三种煤表面的吸附规律，研究结果表明：铜离子能够改善煤的制浆效果，即铜离子加入煤浆中，分散剂的用量降低５０％，煤浆浓度提高；钙、镁、钴、锌离子对煤的成浆性不利的原因是它们不能有效地被吸附到煤表面，游离的金属离子和分散剂发生反应，使得吸附到煤表面的分散剂相对减少，煤的成浆性变差。     

Quantum chemistry study on B32 and B32H2–32

The structures of B32 and B₃₂H^2–₃₂ with I_h symmetry have been investigated by means of ab initio calculations at STO-3G level. The relationship between molecular orbitals of them has been analyzed and their bonding properties have been discussed. Then the possibility of their existence, as well as the similarity and difference between B₃₂ (B₃₂H^2–₃₂) and C₆₀ (C₆₀H₆₀) have been inferred.     

A green strategy for lithium isotopes separation by using mesoporous silica materials doped with ionic liquids and benzo-15-crown-5

Three new mesoporous silica materials IL15SGs (HF15SG, TF15SG and DF15SG) doped with benzo-15-crown-5 and imidazolium based ionic liquids (C₈mim⁺PF₆ ^?, C₈mim⁺BF₄ ^? or C₈mim⁺NTf ₂ ^? ) have been prepared by a simple approach to separating lithium isotopes. The formed mesoporous structures of silica gels have been confirmed by transmission electron microscopy image and N₂ gas adsorption–desorption isotherm. Imidazolium ionic liquids acted as templates to prepare mesoporous materials, additives to stabilize extractant within silica gel, and synergetic agents to separate the lithium isotopes. Factors such as lithium salt concentration, initial pH, counter anion of lithium salt, extraction time, and temperature on the lithium isotopes separation were examined. Under optimized conditions, the extraction efficiency of HF15SG, TF15SG and DF15SG were found to be 11.43, 10.59 and 13.07 %, respectively. The heavier isotope ⁷Li was concentrated in the solution phase while the lighter isotope ⁶Li was enriched in the gel phase. The solid–liquid extraction maximum single-stage isotopes separation factor of ⁶Li–⁷Li in the solid–liquid extraction was up to 1.046 ± 0.002. X-ray crystal structure analysis indicated that the lithium salt was extracted into the solid phase with crown ether forming [(Li_0.5)₂(B15)₂(H₂O)]⁺ complexes. IL15SGs were also easily regenerated by stripping with 20 mmol L^?1 HCl and reused in the consecutive removal of lithium ion in five cycles.     

Design and preliminary assessment of 99mTc-labeled ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/magnetic resonance imaging of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) has a very high incidence and mortality. Early diagnosis and timely treatments are therefore required to improve the quality of life and survival rate of HCC patients. Here, we developed a vascular endothelial growth factor (VEGF)-based multimodality imaging agent for single photon emission computed tomography (SPECT), computed tomography (CT) and magnetic resonance imaging (MRI) and used it to assess HCC mice and explore the combinative value of CT/MRI-based morphological imaging and SPECT functional imaging. HCC targeting with ¹²⁵I-labeled bevacizumab monoclonal antibody (mAb) was examined using SPECT/CT in HepG2 tumor-bearing mice after intravenous mAb injection. Based on this, an integrated, bimodal, VEGF-targeted, ultrasmall superparamagnetic iron oxide (USPIO)-conjugated ^99mTc-labeled bevacizumab mAb was synthesized to increase tumor penetration and accumulations. The in vivo pharmacokinetics and HepG2 tumor targeting were explored through in vivo planar imaging and SPECT/CT using a mouse model of HepG2 liver cancer. The specificity of the radiolabeled nanoparticles for HepG2 HCC was verified using in vitro immunohistochemistry and Prussian blue staining. With diethylenetriamine pentaacetic acid as a bifunctional chelating agent, USPIO-bevacizumab achieved a ^99mTc labeling efficiency of >90 %. The in vivo imaging results also exhibited the targeting of USPIO on HepG2 HCC. The specificity of these results was confirmed using in vitro immunohistochemistry and Prussian blue staining. Our preliminary findings showed the potential of USPIO as an imaging agent for the SPECT/MRI of HepG2 HCC.     

Purification and Characterization of a Urethanase from Penicillium variabile

Urethanase produced by Penicillium variabile was purified through ultrasonication, concentration by polyethylene glycol 20,000, and Superdex G-200 gel filtration chromatography. The molecular weight of urethanase was determined to be around 96 kDa by gel filtration. The purified enzyme showed a single band in SDS-PAGE with the molecular weight of ~13.7 kDa, which suggests that the enzyme has a multimeric structure composed of the same subunits. Peptide map fingerprinting analysis was then carried out by MALDI/TOF-TOF MS. Within the known sequences in NCBI, glucosamine-6-phosphate deaminase and 6-phosphogluconate dehydrogenase get high score as compared with urethanase. Sequence analysis informs that N-terminal sequence of urethanase is GTNTADNDAA. The Minchaelis constant (K _m) and maximum reaction rate (V _m) of urethanase are 27.2 mmol/L and 156.25 μmol/L min, respectively.